References
- Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012;120:2454–2465.
- Haase D, Germing U, Schanz J, et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007;110:4385–4395.
- Baer MR, Bloomfield CD. Trisomy 13 in acute leukemia. Leuk Lymphoma 1992;7:1–6.
- Guo-yu H, Chao-hui Y, Kui T, et al. Atypical chronic myeloid leukaemia with trisomy 13: a case report. Chin Med Sci J 2011;26:254–256.
- Herold T, Metzeler KH, Vosberg S, et al. Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. Blood 2014;124:1304–1311.
- Mesa RA, Hanson CA, Ketterling RP, et al. Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality. Blood 2009;113:1200–1201.
- Fehniger TA, Byrd JC, Marcucci G, et al. Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13. Blood 2009;113:1002–1005.
- Limon J, Baran W, Babinska M, et al. Trisomy 13 in a case of myelodysplastic syndrome. Cancer Genet Cytogenet 1989;37:153–156.
- Beverstock GC, Ploem JE, Wessels H, et al. Trisomy 13 and myelodysplastic syndrome. Cancer Genet Cytogenet 1990;48:179–182.
- Mehta AB, Bain BJ, Fitchett M, et al. Trisomy 13 and myeloid malignancy – characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey. Br J Haematol 1998;101:749–752.
- Sole F, Woessner S, Acin P, et al. Trisomy 13 in a patient with a myelodysplastic syndrome. Cancer Genet Cytogenet 1995;81:185.
- Luciano L, Polito P, Catalano L, et al. Trisomy 13 in a patient with leukemic progression of myelodysplasia. Cancer Genet Cytogenet 1993;69:136–138.
- Kuchenbauer F, Kern W, Schoch C, et al. Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Haematologica 2005;90:1617–1625.
- Lindsley RC, Mar BG, Mazzola E, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood 2015;125: 1367–1376.
- Malcovati L, Papaemmanuil E, Ambaglio I, et al. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. Blood 2014;124:1513–1521.